Comparison of correlations between lipid profile and different computed tomography fatty liver criteria in the setting of incidentally noted fatty liver on computed tomography examinations

No abstract is available for this paper.

• Publication year

  2017

• Venue

  European Journal of Gastroenterology and Hepathology

• Publication date

  2017-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MEG.0000000000000972PMID 28957871
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies.

  2016cited by this paper
• Treatment of Nonalcoholic Fatty Liver Disease: The Role of Medical, Surgical, and Endoscopic Weight Loss

  2015cited by this paper
• Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study.

  2015cited by this paper
• MDCT classification of steatotic liver: a multicentric analysis

  2015cited by this paper
• Noninvasive assessment of macrovesicular liver steatosis in cadaveric donors based on computed tomography liver‐to‐spleen attenuation ratio

  2015cited by this paper
• Non-invasive methods for the diagnosis of nonalcoholic fatty liver disease.

  2015cited by this paper
• Assessment of liver fat in an obese patient population using noncontrast CT fat percent index.

  2014cited by this paper
• Fatty liver: imaging patterns and pitfalls.

  2013cited by this paper
• Association between inflammatory markers and liver fat: The Multi-Ethnic Study of Atherosclerosis.

  2012cited by this paper
• Specificity of unenhanced CT for non-invasive diagnosis of hepatic steatosis: implications for the investigation of the natural history of incidental steatosis

  2012cited by this paper
• Non-contrasted Computed Tomography for the Accurate Measurement of Liver Steatosis in Obese Patients

  2011cited by this paper
• Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT.

  2010cited by this paper
• Quantitative estimation of the degree of hepatic macrovesicular steatosis in a disease‐free population: A single‐center experience in mainland China

  2009cited by this paper
• Prevalence and associated factors of non‐alcoholic fatty liver disease in patients with type‐2 diabetes mellitus

  2009cited by this paper
• Imaging-based quantification of hepatic fat: methods and clinical applications.

  2009cited by this paper
• Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance.

  2009cited by this paper
• Evaluation of diffuse liver steatosis by ultrasound, computed tomography, and magnetic resonance imaging: which modality is best?

  2009cited by this paper
• Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review.

  2008cited by this paper
• Non-invasive means of measuring hepatic fat content.

  2008cited by this paper
• Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index.

  2007cited by this paper
• Comparison of CT methods for determining the fat content of the liver.

  2007cited by this paper
• Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients

  2007cited by this paper
• Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment.

  2006cited by this paper
• The natural history of nonalcoholic fatty liver disease: a population-based cohort study.

  2005cited by this paper
• Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings.

  2004cited by this paper
• Prevalence and trends in obesity among US adults, 1999-2000.

  2002cited by this paper
• Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?

  2002cited by this paper
• Nonalcoholic fatty liver disease.

  2002cited by this paper
• Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

  2001cited by this paper
• Fatty Infiltration of Liver in Hyperlipidemic Patients

  2000cited by this paper
• Diagnostic criteria for fatty infiltration of the liver on contrast-enhanced helical CT.

  1998cited by this paper
• Diagnosis of fatty infiltration of the liver on contrast enhanced CT: limitations of liver-minus-spleen attenuation difference measurements

  1998cited by this paper
• Qualitative assessment of liver for fatty infiltration on contrast-enhanced CT: is muscle a better standard of reference than spleen?

  1997cited by this paper
• Noninvasive in vivo quantitative assessment of fat content in human liver.

  1997cited by this paper
• Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis

  1995cited by this paper
• Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors

  1990cited by this paper
• Quantitative evaluation of fatty liver by computed tomography in rabbits.

  1984cited by this paper
• Evaluation of liver steatotic and fibrous content by computerized tomography and ultrasound.

  1983cited by this paper
• Computed tomography in the diagnosis of fatty liver: total lipid content and computed tomography number.

  1982cited by this paper
• Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease.

  1980cited by this paper

• Comparison of accuracy of CT parameters across chest, low-dose lung, and abdominal CT in diagnosing steatotic liver disease

  2025cites this paper
• Characterization of gallbladder stones associated with occult pancreaticobiliary reflux using computed tomography

  2025cites this paper
• Can Opportunistic Use of Computed Tomography Help Reveal the Association Between Hepatic Steatosis and Disease Severity in Hospitalized COVID-19 Patients?

  2024cites this paper
• Hepatic parenchymal hypoattenuation in dogs with diabetes mellitus on computed tomography consistent with hepatic steatosis

  2024cites this paper
• Correlation between CT Abdominal Anthropometric Measurements and Liver Density in Individuals with Non-Alcoholic Fatty Liver Disease

  2023cites this paper
• Novel measures for the diagnosis of hepatic steatosis using contrast-enhanced computer tomography images.

  2023cites this paper
• The Association of Nonalcoholic Fatty Liver Disease With Neutrophil-to-Lymphocyte Ratio and Neutrophil-Percentage-to-Albumin Ratio

  2023cites this paper
• The imaging techniques and diagnostic performance of ultrasound, CT, and MRI in detecting liver steatosis and fat quantification: A systematic review

  2023cites this paper
• Correlation between Coronary Artery Disease and Non-Alcoholic Fatty Liver Disease Using Computed Tomography Coronary Calcium Scans

  2023cites this paper
• Nicotinamide supplementation in diabetic nonalcoholic fatty liver disease patients: randomized controlled trial

  2022cites this paper
• Hepatic Steatosis Index and the Risk of Type 2 Diabetes Mellitus in China: Insights from a General Population-Based Cohort Study

  2022cites this paper
• Abdominal virtual non-contrast images derived from energy spectrum CT to evaluate chemotherapy-related fatty liver disease

  2022cites this paper
• Current Techniques and Future Trends in the Diagnosis of Hepatic Steatosis in Liver Donors: A Review

  2022cites this paper
• Effects of CPAP on Metabolic Syndrome in Patients with Obstructive Sleep Apnea: a Randomized Trial.

  2022cites this paper
• Association of Hepatic Steatosis Index with Nonalcoholic Fatty Liver Disease Diagnosed by Non-Enhanced CT in a Screening Population

  2021influential citation
• Lipid Profile Response to Electroacupuncture in Non-Alcoholic Fatty Liver Patients with Hyperlipidemia

  2021cites this paper
• Comparison of computed tomography hepatic steatosis criteria for identification of abnormal liver function and clinical risk factors, in incidentally noted fatty liver

  2020cites this paper